Achieve Life Sciences, Inc. logo

Achieve Life Sciences, Inc.

NASDAQ:ACHV

Overview | Financials
Company Name Achieve Life Sciences, Inc.
Symbol ACHV
Currency USD
Price 4.165
Market Cap 143,031,515
Dividend Yield 0%
52-week-range 3.03 - 5.98
Industry Biotechnology
Sector Healthcare
CEO Mr. John A. Bencich M.B.A.
Website https://www.achievelifesciences.com

An error occurred while fetching data.

About Achieve Life Sciences, Inc.

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal

Related Stocks

Dyadic International, Inc. logo

Dyadic International, Inc.

DYAI

1.26 USD

Lantern Pharma Inc. logo

Lantern Pharma Inc.

LTRN

3.42 USD

BioVie Inc. logo

BioVie Inc.

BIVI

2.49 USD

CASI Pharmaceuticals, Inc. logo

CASI Pharmaceuticals, Inc.

CASI

6.5 USD

Entera Bio Ltd. logo

Entera Bio Ltd.

ENTX

1.79 USD

SELLAS Life Sciences Group, Inc. logo

SELLAS Life Sciences Group, Inc.

SLS

1.19 USD

Seelos Therapeutics, Inc. logo

Seelos Therapeutics, Inc.

SEEL

0.228 USD

Financials

Numbers are in millions USD

Numbers are in millions USD